The Drug Enforcement Administration proposes to remove [\123\I]ioflupane from the schedules of the Controlled Substances Act. This action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after an opportunity for a hearing through formal rulemaking. [\123\I]Ioflupane is, by definition, a schedule II controlled substance because it is derived from cocaine via ecgonine, both of which are schedule II controlled substances. This action would remove the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle [\123\I]ioflupane.
Document
Schedules of Controlled Substances: Removal of [123
The Drug Enforcement Administration proposes to remove [\123\I]ioflupane from the schedules of the Controlled Substances Act. This action is pursuant to the Controlled Substance...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 31521
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Schedules of Controlled Substances: Removal of [123,” thefederalregister.org (June 3, 2015), https://thefederalregister.org/documents/2015-13455/schedules-of-controlled-substances-removal-of-123.